𝛼SK or Search

ENTITY

BillionToOne (BLLN US)

20

Analysis

Health Care • United States

BillionToOne, Inc. operates as a diagnostics company. The Company provides quantitative counting templates that detects genetic disorders in the developing baby from maternal blood, as well as invents in the patent-pending molecular counter platform, which increases the resolution of cell-free DNA detection. BillionToOne serves customers in the United States.

more

Refresh

Exchange Announcement • 06 Aug 2026 04:42

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 30 Jun 2026 04:08

Current Report (Form 8-K | Period ending 2026-06-23)

Exchange Announcement • 17 Jun 2026 04:57

Current Report (Form 8-K | Period ending 2026-06-10)

Exchange Announcement • 07 May 2026 04:11

Current Report (Form 8-K | Period ending 2026-05-06)

Exchange Announcement • 06 May 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x